Major owner of Synta Pharmaceuticals Corp. just picked up 1,250,000 shares


Bruce Kovner, a major owner of Synta Pharmaceuticals Corp. and a director of the company, recently acquired 1,250,000 shares of the company. The buys took place at $4.01 per share, on April 11, 2014. Kovner now owns 29,891,849 shares of the company. Kovner operates out of Princeton, NJ. Some additional info was provided as follows:

Reflects the transfer of 778,336 shares from KFO Holdings, LLC to OB Select Opportunities, LLC since the last filing by the Reporting Person. These shares are owned directly by KFO Holdings LLC ("KFO") and indirectly by the Reporting Person as the sole member of KFO. Reflects the transfer of 3,081,664 shares from the Reporting Person to OB Select Opportunities, LLC since the last filing by the Reporting Person. These shares are owned direc tly by OB Select Opportunities, LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of OB Select Opportunities, LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Reflects the transfer of 125,000 shares from the Kovner 2011-A Investment Trust to Kovner 2011 Family Trust since the last filing by the Reporting Person. These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. Synta Pharmaceuticals Corp. next reports earnings on April 28, 2014.

To receive a free e-mail notification whenever Synta Pharmaceuticals Corp. makes a similar move, sign up!

   Auto Refresh

Feedback